← Open Payments lookup

KIMBERLY ORLECK: Open Payments

NPI 1952632580 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$176,791 in 307 payments from 11 companies in 2025. Trend: 2023 $192,062 · 2024 $177,819 · 2025 $176,791

Speaker / faculty: $130,287Consulting: $29,580Travel & lodging: $12,579Food & beverage: $4,260Education: $85
CompanyPaymentsAmount
Janssen Biotech, Inc.92$71,754
ABBVIE INC.107$54,295
PFIZER INC.24$20,584
Lilly USA, LLC15$11,382
Phathom Pharmaceuticals, Inc.12$6,663
Salix Pharmaceuticals, a division of Bausch Health US, LLC17$4,428
Ardelyx, Inc.24$3,407
Takeda Pharmaceuticals U.S.A., Inc.13$3,357
GENZYME CORPORATION1$882
Celltrion USA Inc.1$20

Products named: TREMFYA, VELSIPITY, SKYRIZI, RINVOQ, OMVOH, VOQUEZNA, VIBERZI, LINZESS.

Industry payments across GA — which companies pay providers there.